FDA

New Study Finds No Cognitive Impairment in Kratom Users

A new study published online December 15 by the Journal of Psychoactive Drugs found regular kratom users suffered no significant cognitive impairment. The study, conducted by kratom scientist Darshan Singh and others, focused on 100 participants from the Teluk Kumbar area, a town on the Penang Island of Malaysia. Seventy-five participants had been regular kratom …

New Study Finds No Cognitive Impairment in Kratom Users Read More »

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom

An open letter to HHS, DEA, NIDA, and FDA signed by twelve leading scientists from various fields has been posted on the website of American Kratom Association. The 33 page letter analyzes and sharply criticizes, piece by piece, the FDA’s 8-Factor Analysis that led the organization to determine that kratom should be placed on the …

Scientists’ Letter to HHS, DEA, FDA, NIDA questions FDA’s handling of Kratom Read More »

Will the FDA Urge the DEA to Make Romaine a Schedule 1 Lettuce?

Kratom supplies are being choked off to American consumers by the actions of both the Indonesian government and the FDA under Trump-appointed Commissioner Scott Gottlieb, M.D. Post mid-term election speculation is appearing all over the internet as to whether the DEA will classify kratom as a Schedule 1 substance, or the FDA will continue to …

Will the FDA Urge the DEA to Make Romaine a Schedule 1 Lettuce? Read More »

Kratom Stories: US Navy Veteran and Kratom Activist Andrew Turner

Andrew Turner appeared in the recent Netflix documentary about kratom entitled A Leaf of Faith, directed by Chris Bell (Bigger Stronger Faster, Prescription Thugs). Turner is a veteran of the United States Navy and served in Iraq and Guantanamo Bay. He is an outspoken advocate for keeping kratom legal. He lives in the Washington DC …

Kratom Stories: US Navy Veteran and Kratom Activist Andrew Turner Read More »

Here’s why we must continue to study Kratom and other opioid-like drugs

BY PAULA N. BROWN, OPINION CONTRIBUTOR — 07/07/18 04:00 PM EDT 36 THE VIEWS EXPRESSED BY CONTRIBUTORS ARE THEIR OWN AND NOT THE VIEW OF THE HILL The U.S. Food and Drug Administration (FDA) recently gave final approval for the first non-opioid drug shown to lessen the severity of opioid withdrawal symptoms. Meanwhile, President Trump signed into law groundbreaking …

Here’s why we must continue to study Kratom and other opioid-like drugs Read More »